Post

PREPRINT (not peer-reviewed). Why do two related β-lactam antibiotics leave L1 metallo-β-lactamase in different product poses? Kalita and colleagues’ QM/MM study predicts that both ertapenem and faropenem begin with similar ring-opening steps, but ertapenem’s 1β-methyl group makes the rotation needed for the faropenem-like route much less favorable. Instead, rotation of ertapenem’s C6-carboxyl group offers a lower-barrier path to the (2S)-imine-Δ1 product in the binding mode seen crystallographically. In three 500 ns molecular-dynamics replicas, that ertapenem-derived imine also dissociated within 150 ns, whereas the faropenem-derived species stayed bound under the simulated conditions. These are model-dependent computational predictions, not direct measurements of enzyme kinetics or product residence times. Find the paper on ChemRxiv by searching the full title: QM/MM Simulations Reveal Differences in Hydrolysis Mechanisms of Ertapenem and Faropenem in L1 Metallo-β-Lactamase Leading to Different Product Binding Modes.

2:38:42 AM · Nov 23, 2026
Sign in to reply and join the conversation.